Literature DB >> 27179721

Family history of atrial fibrillation is associated with earlier-onset and more symptomatic atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.

Anna Gundlund1, Emil Loldrup Fosbøl2, Sunghee Kim3, Gregg C Fonarow4, Bernard J Gersh5, Peter R Kowey6, Elaine Hylek6, Kenneth W Mahaffey7, Laine Thomas3, Jonathan P Piccini3, Eric D Peterson3.   

Abstract

BACKGROUND: We addressed whether patients with a family history of atrial fibrillation (AF) were diagnosed as having AF earlier in life, were more symptomatic, and had worse outcomes compared with those without a family history of AF.
METHODS: Using the ORBIT-AF, we compared symptoms and disease characteristics in those with and without a family history of AF. A family history of AF was defined as AF in a first-degree family member and obtained by patient self-reporting. Multivariable Cox proportional hazard analyses were performed to compare the incidence of cardiovascular outcomes, AF progression, all-cause hospitalization, and all-cause death.
RESULTS: Among 9,999 patients with AF from 176 US outpatient clinics, 1,481 (14.8%) had a family history of AF. Relative to those without, those with a family history of AF developed AF 5 years earlier on average (median age 65 vs 70 years, P < .01), with less comorbidity, and had more severe AF-related symptoms. No differences were found between the 2 groups in the risk of AF progression (adjusted hazard ratio [HR] 0.98, 95% CI 0.85-1.14), stroke, non-central nervous system embolism, or transient ischemic attack (adjusted HR 0.95, 95% CI 0.67-1.34), all-cause hospitalization (adjusted HR 1.03, 95% CI 0.94-1.12), and all-cause death (adjusted HR 1.05, 95% CI 0.86-1.27).
CONCLUSIONS: Patients with a family history of AF developed AF at a younger age, had less comorbidity, and were more symptomatic. Once AF developed, no significantly increased risks of AF progression and thromboembolism were associated with a family history of AF compared with no family history.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27179721     DOI: 10.1016/j.ahj.2016.01.020

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  11 in total

1.  Genetic Susceptibility for Atrial Fibrillation in Patients Undergoing Atrial Fibrillation Ablation.

Authors:  M Benjamin Shoemaker; Daniela Husser; Carolina Roselli; Meelad Al Jazairi; Jonathan Chrispin; Michael Kühne; Benjamin Neumann; Stacey Knight; Han Sun; Sanghamitra Mohanty; Christian Shaffer; Sébastien Thériault; Lauren Lee Rinke; Joylene E Siland; Diane M Crawford; Laura Ueberham; Omeed Zardkoohi; Petra Büttner; Bastiaan Geelhoed; Steffen Blum; Stefanie Aeschbacher; Jonathan D Smith; David R Van Wagoner; Rebecca Freudling; Martina Müller-Nurasyid; Jay Montgomery; Zachary Yoneda; Quinn Wells; Tariq Issa; Peter Weeke; Victoria Jacobs; Isabelle C Van Gelder; Gerhard Hindricks; John Barnard; Hugh Calkins; Dawood Darbar; Greg Michaud; Stefan Kääb; Patrick Ellinor; Andrea Natale; Mina Chung; Saman Nazarian; Michael J Cutler; Moritz F Sinner; David Conen; Michiel Rienstra; Andreas Bollmann; Dan M Roden; Steven Lubitz
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-02-14

2.  Association of a Family History of Atrial Fibrillation With Incidence and Outcomes of Atrial Fibrillation: A Population-Based Family Cohort Study.

Authors:  Shang-Hung Chang; Chang-Fu Kuo; I-Jun Chou; Lai-Chu See; Kuang-Hui Yu; Shue-Fen Luo; Lu-Hsiang Huang; Weiya Zhang; Michael Doherty; Ming-Shien Wen; Chi-Tai Kuo; Yung-Hsin Yeh
Journal:  JAMA Cardiol       Date:  2017-08-01       Impact factor: 14.676

3.  Characteristics of Atrial Fibrillation Patients with a Family History of Atrial Fibrillation.

Authors:  Shannon M Fan; Amy Fann; Gregory Nah; Mark J Pletcher; Jeffrey E Olgin; Gregory M Marcus
Journal:  J Atr Fibrillation       Date:  2019-06-30

4.  Role of genetics in atrial fibrillation management.

Authors:  Michiel Rienstra; Joylene E Siland; Patrick T Ellinor
Journal:  Europace       Date:  2021-04-10       Impact factor: 5.214

5.  Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.

Authors:  Keith A A Fox; Joseph E Lucas; Karen S Pieper; Jean-Pierre Bassand; A John Camm; David A Fitzmaurice; Samuel Z Goldhaber; Shinya Goto; Sylvia Haas; Werner Hacke; Gloria Kayani; Ali Oto; Lorenzo G Mantovani; Frank Misselwitz; Jonathan P Piccini; Alexander G G Turpie; Freek W A Verheugt; Ajay K Kakkar
Journal:  BMJ Open       Date:  2017-12-21       Impact factor: 2.692

6.  Outcomes Associated With Familial Versus Nonfamilial Atrial Fibrillation: A Matched Nationwide Cohort Study.

Authors:  Anna Gundlund; Jonas Bjerring Olesen; Laila Staerk; Christina Lee; Jonathan P Piccini; Eric D Peterson; Lars Køber; Christian Torp-Pedersen; Gunnar H Gislason; Emil Loldrup Fosbøl
Journal:  J Am Heart Assoc       Date:  2016-11-19       Impact factor: 5.501

7.  Risk of Stroke in Patients With Atrial Fibrillation Is Associated With Stroke in Siblings: A Nationwide Study.

Authors:  John Berntsson; Xinjun Li; Bengt Zöller; Andreas Martinsson; Pontus Andell; Steven A Lubitz; Gunnar Engström; Kristina Sundquist; J Gustav Smith
Journal:  J Am Heart Assoc       Date:  2020-02-03       Impact factor: 5.501

8.  Whole-exome sequencing reveals a rare missense variant in DTNA in an Iranian pedigree with early-onset atrial fibrillation.

Authors:  Mahshid Malakootian; Masoumeh Jalilian; Samira Kalayinia; Maryam Hosseini Moghadam; Mona Heidarali; Majid Haghjoo
Journal:  BMC Cardiovasc Disord       Date:  2022-02-11       Impact factor: 2.298

9.  Plasma growth differentiation factor-15 in patients with "lone" atrial fibrillation.

Authors:  Na Li; Qian Feng; Fangfang Yu; Jian Zhou; Xueyuan Guo
Journal:  J Clin Lab Anal       Date:  2022-03-25       Impact factor: 3.124

10.  GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation.

Authors:  Keith A A Fox; Saverio Virdone; Karen S Pieper; Jean-Pierre Bassand; A John Camm; David A Fitzmaurice; Samuel Z Goldhaber; Shinya Goto; Sylvia Haas; Gloria Kayani; Ali Oto; Frank Misselwitz; Jonathan P Piccini; Frederik Dalgaard; Alexander G G Turpie; Freek W A Verheugt; Ajay K Kakkar
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2022-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.